Publicaciones en colaboración con investigadores/as de Eli Lilly and Company (2)

2003

  1. Safety, effectiveness, and quality of life of olanzapine in first-episode schizophrenia: A naturalistic study

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 27, Núm. 4, pp. 667-674